Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130389 · ClinicalTrials.gov registry record
CONDOR Study of Osteonecrosis of the Jaws (TMJ)
A clinical trial of Osteonecrosis of the Jaw, sponsored by Dental Practice-Based Research Network.
- Completed
- Registry status
- 309
- Enrollment target
- 5
- Study locations
NCT01130389 is a study of Osteonecrosis of the Jaw that has completed, run by Dental Practice-Based Research Network. The registered enrollment target is 309 participants. The trial reports 5 study locations across 3 states.
The verdict
NCT01130389, a study of Osteonecrosis of the Jaw, has completed, sponsored by Dental Practice-Based Research Network.
- COMPLETED
- Registry status
- 309 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study was to examine risk factors for osteonecrosis of the jaw (ONJ), including the possible association with bisphosphonates (BPs). This study used the research infrastructure from the three NIDCR-funded dental practice-based research networks (DPBRN, PEARL, PRECEDENT). De-identified data from the DPBRN were merged with comparable de-identified data from PEARL and PRECEDENT to form a single trans-PBRN data set used for analysis.
Conditions Studied
Study Locations (5)
Minnesota
- Health Partners Dental Group - Minneapolis
- Health Partners Research Foundation - Minneapolis
Oregon
- Kaiser Permanente Center for Health Research - Portland
- Permanente Denrtal Associates - Portland
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130389
The ClinicalTrials.gov registry entry for NCT01130389 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dental Practice-Based Research Network, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteonecrosis of the Jaw appearing as the primary indexed condition, and to 0 interventions.
NCT01130389 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, Oregon, Alabama.
Frequently Asked Questions
What is clinical trial NCT01130389 about?
NCT01130389 is a clinical study titled "CONDOR Study of Osteonecrosis of the Jaws (TMJ)". The purpose of this study was to examine risk factors for osteonecrosis of the jaw (ONJ), including the possible association with bisphosphonates (BPs). This study used the research infrastructure from the three NIDCR-funded dental practice-based research networks (DPBRN, PEARL, PRECEDENT). De-ident...
What is the current status of trial NCT01130389?
This trial is currently completed. The enrollment target is 309 participants. The study started on 2007-01. Estimated completion is 2008-09.
What conditions does trial NCT01130389 study?
This clinical trial studies the following conditions: Osteonecrosis of the Jaw.
Who is sponsoring clinical trial NCT01130389?
This trial is sponsored by Dental Practice-Based Research Network, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01130389 being conducted?
This trial has 5 study locations across Alabama, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteonecrosis of the Jaw
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.